Vanda Pharmaceuticals Cash from Other Financing Activities (Quarterly) Insights

Vanda Pharmaceuticals, Inc. (VNDA)

8.16 +2.40 (+41.67%) USD | NASDAQ | Feb 23, 16:00

8.29 +0.13 (+1.59%) After-Hours: 16:49

View Cash from Other Financing Activities (Quarterly) for VNDA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Cash from Other Financing Activities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Cash from Other Financing Activities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Cash from Other Financing Activities (Quarterly) Benchmarks

Start Trial

Eli Lilly & Co.	Upgrade
Axsome Therapeutics, Inc.	Upgrade
AnaptysBio, Inc.	Upgrade
SELLAS Life Sciences Group, Inc.	--
Protagenic Therapeutics, Inc.	--